Literature DB >> 8882138

Behçet disease: advantageous against development of neoplasia?

I Celík, I Barişta, G Tekuzman, E Kansu, S Kíraz, M Calgünerí.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8882138      PMCID： PMC1010264          DOI： 10.1136/ard.55.9.648-a

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  7 in total

1.  [Angiocentric lymphoma in Behçet's disease].

Authors:  I Moulonguet-Michau; F Blanc; B Cavelier-Balloy; P Brice; B Flageul; J Civatte
Journal:  Ann Dermatol Venereol       Date:  1990       Impact factor: 0.777

2.  [Erythroleukemia in a patient with Behçet's disease under long-term thalidomide therapy].

Authors:  B Louzir; S Othmani; N Gritli; M Beji; B Zidi; F M'Saddek; E Boussema; M Bahri
Journal:  Ann Med Interne (Paris)       Date:  1992

3.  HLA antigens in Behçet's disease: a reappraisal by a comparative study of Turkish and British patients.

Authors:  H Yazici; M A Chamberlain; I Schreuder; J D'Amaro; M Muftuoglu
Journal:  Ann Rheum Dis       Date:  1980-08       Impact factor: 19.103

4.  [Hodgkin's disease associated with Behçet's disease].

Authors:  S Kawamoto; H Terada; H Niikura; T Kumasaka; S Saiki
Journal:  Rinsho Ketsueki       Date:  1992-02

5.  [Behçet's disease. 316 cases].

Authors:  S Benamour; B Zeroual; R Bennis; A Amraoui; S Bettal
Journal:  Presse Med       Date:  1990-10-06       Impact factor: 1.228

Review 6.  Gastric non-Hodgkin's lymphoma associated with Behçet's disease.

Authors:  T Abe; A Yachi; T Yabana; Y Ishii; M Tosaka; Y Yoshida; K Yonezawa; A Ono; N Ikeda; M Matsuya
Journal:  Intern Med       Date:  1993-08       Impact factor: 1.271

7.  The prevalence of Sjögren's syndrome in Behçet's syndrome.

Authors:  I Günaydin; C Ustündağ; G Kaner; H Pazarli; S Yurdakul; V Hamuryudan; Y Yazici; H Yazici
Journal:  J Rheumatol       Date:  1994-09       Impact factor: 4.666
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.